Asarfi Hospital Limited (BOM:543943)

Asarfi Hospital Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	1,606	1,206	844	707.03	652.13	541.22
Revenue Growth (YoY)	45.02%	42.85%	19.37%	8.42%	20.49%	26.25%
Cost of Revenue	622.01	469.27	350.23	339.25	357.44	316.31
Gross Profit	983.58	736.38	493.78	367.79	294.69	224.91
Selling, General & Admin	28.58	28.58	25.3	17.42	11.47	7.71
Other Operating Expenses	644.6	472.33	307.82	212.65	175.36	135.28
Operating Expenses	793.54	627.66	421	268.8	220.3	173.68
Operating Income	190.04	108.72	72.78	98.99	74.39	51.23
Interest Expense	-48.42	-40.37	-22.79	-8.67	-2.31	-4.71
Interest & Investment Income	12.08	12.08	7.03	2.18	2.94	1.68
Other Non Operating Income (Expenses)	35.84	26.32	5.4	16.38	2.15	-0.47
EBT Excluding Unusual Items	189.53	106.75	62.41	108.89	77.17	47.74
Gain (Loss) on Sale of Assets	3.98	3.98	-	-	-	-
Other Unusual Items	32.38	32.38	-	-	-	-
Pretax Income	225.9	143.11	62.41	108.89	77.17	47.74
Income Tax Expense	62.58	37.35	20.8	28.73	19.88	12.39
Net Income	163.31	105.76	41.62	80.15	57.28	35.34
Preferred Dividends & Other Adjustments	-0	-0	-	-	-	-
Net Income to Common	163.31	105.76	41.62	80.15	57.28	35.34
Net Income Growth	140.96%	154.13%	-48.08%	39.92%	62.08%	34.51%
Shares Outstanding (Basic)	20	20	18	11	7	7
Shares Outstanding (Diluted)	20	20	18	11	7	7
Shares Change (YoY)	0.10%	9.02%	70.59%	41.13%	-	0.00%
EPS (Basic)	8.31	5.37	2.31	7.58	7.64	4.71
EPS (Diluted)	8.30	5.37	2.31	7.58	7.64	4.71
EPS Growth	140.59%	132.91%	-69.56%	-0.84%	62.21%	34.39%
Free Cash Flow	-79.43	-161.37	-200	-222.06	-102.53	19.33
Free Cash Flow Per Share	-4.04	-8.20	-11.08	-20.99	-13.68	2.58
Gross Margin	61.26%	61.08%	58.50%	52.02%	45.19%	41.56%
Operating Margin	11.84%	9.02%	8.62%	14.00%	11.41%	9.47%
Profit Margin	10.17%	8.77%	4.93%	11.34%	8.78%	6.53%
Free Cash Flow Margin	-4.95%	-13.38%	-23.70%	-31.41%	-15.72%	3.57%
EBITDA	310.4	235.48	160.66	137.73	107.86	80.35
EBITDA Margin	19.33%	19.53%	19.04%	19.48%	16.54%	14.85%
D&A For EBITDA	120.36	126.76	87.88	38.74	33.47	29.12
EBIT	190.04	108.72	72.78	98.99	74.39	51.23
EBIT Margin	11.84%	9.02%	8.62%	14.00%	11.41%	9.47%
Effective Tax Rate	27.70%	26.10%	33.32%	26.39%	25.77%	25.96%
Revenue as Reported	1,690	1,281	860.71	730.33	661.95	543.99
Advertising Expenses	-	8.15	5.98	17.31	11.12	6.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.